Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocco Buccheri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|August 28, 2025
High-Throughput, High-Quality: Benchmarking GNINA and AutoDock Vina for Precision Virtual Screening WorkflowRocco Buccheri, Antonio Rescifina
Journal of Chemical Information and Modeling|May 29, 2026
A Reproducible Hierarchical Virtual Screening Framework Integrating Scaffold-Aware Machine Learning, Ensemble Docking, and Molecular Dynamics: Application to IDO1Elisabetta Grazia Tomarchio, Rocco Buccheri, Antonio Rescifina
Chemical Biology & Drug Design|July 1, 2026
In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-TelangiectasiaAlessia Romano, Rocco Buccheri, Chiara Zagni, et al.
Bioorganic Chemistry|July 14, 2026
An integrated in silico and SPR-based workflow identifies FDA-approved drugs as previously unrecognized SIRT3 bindersRocco Buccheri, Alessia Distefano, Chiara Zagni, et al.
International Journal of Molecular Sciences|January 25, 2025
Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking StudiesRocco Buccheri, Alessandro Coco, Lorella Pasquinucci, et al.
International Journal of Molecular Sciences|May 13, 2026
Structure-Guided Repurposing of Approved Drugs Identifies Aprepitant and Mavorixafor as Putative δ-Opioid Receptor Agonist CandidatesRocco Buccheri, Carlo Reale, Alessandro Coco, et al.
International Journal of Molecular Sciences|October 16, 2025
Synthesis and Biological Profile of Omaveloxolone: The Cornerstone for Friedreich Ataxia TreatmentMassimiliano Cordaro, Giulia Neri, Shoeb Anwar Mohammed Khawja Ansari, et al.
European Journal of Medicinal Chemistry|July 30, 2025
Targeting histone deacetylase 1: Inhibition and activation as promising therapeutic strategies for diverse disordersGiuliana Costanzo, Rocco Buccheri, Giuseppe Cosentino, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|August 28, 2025
High-Throughput, High-Quality: Benchmarking GNINA and AutoDock Vina for Precision Virtual Screening WorkflowRocco Buccheri, Antonio Rescifina
Journal of Chemical Information and Modeling|May 29, 2026
A Reproducible Hierarchical Virtual Screening Framework Integrating Scaffold-Aware Machine Learning, Ensemble Docking, and Molecular Dynamics: Application to IDO1Elisabetta Grazia Tomarchio, Rocco Buccheri, Antonio Rescifina
Chemical Biology & Drug Design|July 1, 2026
In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-TelangiectasiaAlessia Romano, Rocco Buccheri, Chiara Zagni, et al.
Bioorganic Chemistry|July 14, 2026
An integrated in silico and SPR-based workflow identifies FDA-approved drugs as previously unrecognized SIRT3 bindersRocco Buccheri, Alessia Distefano, Chiara Zagni, et al.
International Journal of Molecular Sciences|January 25, 2025
Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking StudiesRocco Buccheri, Alessandro Coco, Lorella Pasquinucci, et al.
International Journal of Molecular Sciences|May 13, 2026
Structure-Guided Repurposing of Approved Drugs Identifies Aprepitant and Mavorixafor as Putative δ-Opioid Receptor Agonist CandidatesRocco Buccheri, Carlo Reale, Alessandro Coco, et al.
International Journal of Molecular Sciences|October 16, 2025
Synthesis and Biological Profile of Omaveloxolone: The Cornerstone for Friedreich Ataxia TreatmentMassimiliano Cordaro, Giulia Neri, Shoeb Anwar Mohammed Khawja Ansari, et al.
European Journal of Medicinal Chemistry|July 30, 2025
Targeting histone deacetylase 1: Inhibition and activation as promising therapeutic strategies for diverse disordersGiuliana Costanzo, Rocco Buccheri, Giuseppe Cosentino, et al.
Pageof 1